Skip to main content
Log in

Entry of diazepam and its major metabolite into cerebrospinal fluid

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Five dogs received a single 1.0 mg/kg dose of diazepam (DZ) IV. Concentrations of DZ and its major metabolite desmethyldiazepam (DMDZ) were simultaneously measured in plasma and cisternal cerebrospinal fluid (CSF) for up to 8 h after the dose by electron-capture gas-liquid chromatography. DZ was rapidly eliminated from plasma (half-life 0.3–1.3 h); DZ disappearance was mirrored by formation of DMDZ, which in turn was eliminated slowly. Both DZ and DMDZ rapidly penetrated CSF and concentrations in CSF declined parallel with those in plasma. Despite rapid uptake, the extent of CSF transfer of DZ and DMDZ was limited by plasma protein binding. Mean CSF: plasma concentration ratios for DZ (range 0.023–0.137) and DMDZ (range 0.047–0.119) were highly correlated with the unbound fraction in plasma (r=0.95 and 0.80, respectively). Thus DZ and DMDZ concentrations in CSF, presumed to reflect concentrations at the site of action, are determined by unbound plasma concentrations. The intensity of pharmacologic action is more likely to correlate with unbound than with total plasma concentrations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Danhof M, Breimer DD (1978) Therapeutic monitoring in saliva. Clin Pharmacokinet 3:39–57

    Google Scholar 

  • Greenblatt DJ (1978) Simultaneous gas-chromatographic analysis of diazepam and its major metabolite, desmethyldiazepam, with use of double internal standardization. Clin Chem 24:1838–1841

    Google Scholar 

  • Greenblatt DJ, Allen MD, Harmatz JS, Shader RI (1980) Diazepam disposition deteminants. Clin Pharmacol Ther 27:301–312

    Google Scholar 

  • Greenblatt DJ, Shader RI, MacLeod SM, Sellers EM (1978) Clinical pharmacokinetics of chlordiazepoxide. Clin Pharmacokinet 3:381–394

    Google Scholar 

  • Jalling B (1974) Plasma and cerebrospinal fluid concentrations of phenobarbital in infants given single doses. Dev med Child Neurol 16:781–793

    Google Scholar 

  • Kangas L, Kanto J, Siirtola T, Pekkarinen A (1977) Cerebrospinal fluid concentrations of nitrazepam in man. Acta Pharmacol Toxicol (Kbh) 41:74–79

    Google Scholar 

  • Kanto J, Kangas L, Siirtola T (1975) Cerebrospinal fluid concentrations of diazepam and its metabolites in man. Acta Pharmacol Toxicol (Kbh) 36:328–334

    Google Scholar 

  • Klotz U, Antonin KH, Bieck PR (1976) Pharmacokinetics and plasma binding of diazepam in man, dog, rabbit, guinea pig and rat. J Pharmacol Exp Ther 199:67–73

    Google Scholar 

  • Koch-Weser J, Sellers EM (1976) Binding of drugs to serum albumin. N Engl J Med 294:311–316, 526–531

    Google Scholar 

  • Leppik IE, Sherwin AL (1979) Intravenous phenytoin and phenobarbital: Anticonvulsant action, brain content, and plasma binding in rat. Epilepsia 20:201–207

    Google Scholar 

  • Lund L, Berlin A, Lunde PKM (1972) Plasma protein binding of diphenylhydantoin in patients with epilepsy. Clin Pharmacol Ther 13:196–200

    Google Scholar 

  • Mandelli M, Tognoni G, Garattini S (1978) Clinical pharmacokinetics of diazepam. Clin Pharmacokinet 3:72–91

    Google Scholar 

  • Ochs HR, Greenblatt DJ, Lloyd BL, Woo E, Sonntag M, Smith TW (1980) Entry of quinidine into cerebrospinal fluid. Am Heart J (in press)

  • Oldendorf WH (1974) Blood-brain barrier permeability to drugs. Annu Rev Pharmacol 14:239–248

    Google Scholar 

  • Ramsay HE, Hammond EJ, Perchalski RJ, Wilder BJ (1979) Brain uptake of phenytoin, phenobarbital, and diazepam. Arch Neurol 36:535–539

    Google Scholar 

  • Rapoport SI (1976) Blood-brain barrier in physiology and medicine. Raven, New York

    Google Scholar 

  • Schmidt D, Kupferberg HJ (1975) Diphenylhydantoin, phenobarbital, and primidone in saliva, plasma, and cerebrospinal fluid. Epilepsia 16:735–741

    Google Scholar 

  • Schwartz MA, Koechlin BA, Postma E, Palmer S, Krol G (1965) Metabolism of diazepam in rat, dog, and man. J Pharmacol Exp Ther 149:423–435

    Google Scholar 

  • Stanski DR, Greenblatt DJ, Selwyn A, Shader RI, Franke K, Koch-Weser J (1976) Plasma and cerebrospinal fluid concentrations of chlordiazepoxide and its metabolites in surgical patients. Clin Pharmacol Ther 20:571–578

    Google Scholar 

  • Troupin AS, Friel P (1975) Anticonvulsant level in saliva, serum, and cerebrospinal fluid. Epilepsia 16:223–227

    Google Scholar 

  • van der Kleijn E, van Rossum JM, Muskens ETJM, Rijntjes NVM (1971) Pharmacokinetics of diazepam in dogs, mice and humans. Acta Pharmacol Toxicol (Kbh) 29:109–127

    Google Scholar 

  • Vree TB, Baars AM, Hekster YA, van der Kleijn E, O'Reilly WJ (1979) Simultaneous determination of diazepam and its metabolites N-desmethyldiazepam, oxydiazepam, and oxazepam in plasma and urine of man and dog by means of high performance liquid chromatography. J Chromatogr 162:605–614

    Google Scholar 

  • Woo E, Greenblatt DJ (1979) Pharmacokinetic and clinical implications of quinidine protein binding. J Pharm Sci 68:466–470

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Greenblatt, D.J., Ochs, H.R. & Lloyd, B.L. Entry of diazepam and its major metabolite into cerebrospinal fluid. Psychopharmacology 70, 89–93 (1980). https://doi.org/10.1007/BF00432376

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00432376

Key words

Navigation